ACADM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.786000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.343400E-01
Normal-vs-Stage2
1.255830E-02
Normal-vs-Stage3
4.855700E-03
Normal-vs-Stage4
4.048200E-02
Stage1-vs-Stage2
1.556580E-01
Stage1-vs-Stage3
9.748400E-02
Stage1-vs-Stage4
9.200600E-01
Stage2-vs-Stage3
1.402620E-01
Stage2-vs-Stage4
5.138000E-03
Stage3-vs-Stage4
5.597400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.812100E-02
Normal-vs-AfricanAmerican
4.236000E-01
Normal-vs-Asian
7.340000E-03
Caucasian-vs-AfricanAmerican
8.512300E-02
Caucasian-vs-Asian
3.300400E-01
AfricanAmerican-vs-Asian
2.515700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.024100E-03
Normal-vs-Female
1.333550E-01
Male-vs-Female
4.625600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.358000E-02
Normal-vs-Age(41-60Yrs)
5.253900E-02
Normal-vs-Age(61-80Yrs)
4.484000E-02
Normal-vs-Age(81-100Yrs)
2.091900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.980800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.747600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.019600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.429600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.420970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.055790E-02
Normal-vs-Daily Drinker
4.773000E-04
Normal-vs-Weekly Drinker
1.062250E-03
Normal-vs-Occasional Drinker
4.112600E-01
Normal-vs-Social Drinker
1.013230E-01
Non Drinker-vs-Daily Drinker
1.444430E-01
Non Drinker-vs-Weekly Drinker
2.513600E-01
Non Drinker-vs-Occasional Drinker
3.439800E-01
Non Drinker-vs-Social Drinker
3.920800E-01
Daily Drinker-vs-Weekly Drinker
9.040000E-01
Daily Drinker-vs-Occasional Drinker
1.072360E-01
Daily Drinker-vs-Social Drinker
5.075700E-02
Weekly Drinker-vs-Occasional Drinker
1.261760E-01
Weekly Drinker-vs-Social Drinker
1.069610E-01
Occasional Drinker-vs-Social Drinker
7.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.538600E-01
Normal-vs-Grade 2
4.195200E-01
Normal-vs-Grade 3
4.944200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.407200E-01
Grade 1-vs-Grade 3
1.502170E-01
Grade 1-vs-Grade 4
4.538600E-01
Grade 2-vs-Grade 3
5.324600E-01
Grade 2-vs-Grade 4
4.195200E-01
Grade 3-vs-Grade 4
4.944200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.882250E-02
Normal-vs-NonDiabetic
2.142100E-02
Diabetic-vs-NonDiabetic
9.161000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.799700E-03
Normal-vs-NoPancreatitis
2.971500E-02
Pancreatitis-vs-NoPancreatitis
1.827570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.323800E-01
Normal-vs-N1
3.878700E-03
N0-vs-N1
3.212400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.159000E-03
Normal-vs-TP53-NonMutant
3.279000E-01
TP53-Mutant-vs-TP53-NonMutant
1.339430E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
